Search Prime Grants

W81XWH2211043

Project Grant

Overview

Grant Description
Development of a non-human primate model for the identification and development of novel therapeutics for dystonia.
Awardee
Atuka
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding Agency
U.S. Army Medical Research Acquisition Activity (USAMRAA) [DoD - USA - MEDCOM - MRDC]
Funding Agency
Medical Command (MEDCOM) [DoD - USA]
Place of Performance
Canada
Geographic Scope
Foreign
Related Opportunity
None
Atuka was awarded Project Grant W81XWH2211043 worth $1,528,921 from Medical Command in September 2022 with work to be completed primarily in Canada. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 9/21/22

Period of Performance
9/30/22
Start Date
9/29/26
End Date
79.0% Complete

Funding Split
$1.5M
Federal Obligation
$0.0
Non-Federal Obligation
$1.5M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to W81XWH2211043

Additional Detail

Award ID FAIN
W81XWH2211043
SAI Number
None
Award ID URI
None
Awardee Classifications
For-Profit Organization (Other Than Small Business)
Other
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Awardee UEI
NCB2RK6F1N57
Awardee CAGE
L0FU5
Performance District
Not Applicable

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Defense Health Program, Defense (097-0130) Department of Defense-Military Grants, subsidies, and contributions (41.0) $1,528,921 100%
Modified: 9/21/22